Chu de Toulouse - Hôpital Des Enfants

Toulouse 31059

3 studies enrolling now · 8 studies all time

What they study most

Dravet Syndrome, Duchenne Muscular Dystrophy, Idiopathic Short Stature, Lupus Nephritis, Obesity, Prader-Willi Syndrome, Progressive Familial Intrahepatic Cholestasis (PFIC), Weight Gain

Studies at this site

• A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) — Recruiting now
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants — Recruiting now
• A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature — Recruiting now
• A Study of Pitolisant in Patients With Prader-Willi Syndrome — Recruiting now
• An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC) — Completed
• A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC) — Completed
• A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome — Completed
• Extension Study of Drisapersen in DMD Subjects — NO_LONGER_AVAILABLE